Refine by
Patient Assessment Articles & Analysis
109 news found
(NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient quality of life, today announced the completion of patient enrollment in the Acute Pulmonary Embolism Extraction Trial with the AlphaVac System (APEX-AV). ...
It is a point-of-care device for assessing airway inflammation in patients with respiratory problems. With over 45 million NIOX® tests undertaken to date, the system is used by healthcare professionals around the world to help improve asthma care. ...
It can aid in the diagnosis of asthma and COPD and can also help identify patients who are at risk of progression to COPD. [1] The tremoflo® C-100 assesses respiratory function through simple tidal breathing and can be a valuable tool when compiling a detailed picture of respiratory function. It is particularly useful in enabling the very young, frail, or ...
In addition, cryolipolysis treatment can also lead to complications if patients are not adequately examined and assessed prior to treatment. 3. ...
Baseline Disease Characteristics of Patients Who Maintained 12- and 16-Week Aflibercept 8 mg Dosing Versus Patients with Shortened Treatment Intervals Through Week 48 in the Phase 2/3 PHOTON Trial Podium presentation April 25, 2023; 12.15-12.30 EST The analysis of the PHOTON trial evaluates the treatment effects of aflibercept 8 mg versus 2 mg at Week 48 ...
ByBayer AG
“We are all united by our ultimate mission of bringing world-class care and treatment to patients around the world, and we strive to foster a culture that encourages collaboration and visionary thinking to help us drive our innovation ...
It is estimated that around 40 percent of eligible patients are either not treated with direct oral anticoagulants or undertreated as these patients assess the bleeding risk to be higher than their need for thrombosis prevention. ...
ByBayer AG
In fact, the disease is responsible for “two million broken bones and $19 billion in related costs every year”, while by the year 2025, “experts predict that osteoporosis will be responsible for approximately three million fractures and $25.3 billion in costs annually.” Sadly, most patients are not aware of having the condition before suffering from a ...
“As we continue to expand our clinical research program, we’re looking forward to improving our trial recruitment efforts with more accurate patient screening and identification, and ultimately, increasing patient access to trials and ...
This award demonstrates the tremendous effort our team puts in everyday to develop technology that will benefit patients everywhere.” Iterative Health was selected from a pool of over 13,000 private companies and was chosen based on its R&D activity, market potential, business relationships, investor profile, competitive landscape, team strength, and tech novelty. ...
” The approval is based on a thorough review by the PMDA of the positive clinical data from the pivotal LIBERATE Study1 that enrolled patients with heterogenous emphysema distribution and the IMPACT Study3 that included patients with homogeneous emphysema distribution. ...
Pulmonx’s Zephyr® Endobronchial Valve, Chartis® Pulmonary Assessment System and StratX® Lung Analysis Platform are designed to assess and treat patients with severe emphysema/COPD who despite medical management are still profoundly symptomatic. ...
Pulmonx’s Zephyr® Endobronchial Valve, Chartis® Pulmonary Assessment System and StratX® Lung Analysis Platform are designed to assess and treat patients with severe emphysema/COPD who despite medical management are still profoundly symptomatic. ...
Wayne Miller, Mayo Clinic, cited data from this study and concluded that “there are limitations to the use of the surrogates, if you need to know information about volume [in heart failure patients], you need to measure volume.” The study titled, “Blood Volume Analysis and Hemodynamic Measures of Vascular Compliance in Patients with Worsening ...
Methods for collecting patient information involve questionnaire-based assessments with branching logic and scoring, computer-assisted telephone interviewing (CATI), interactive voice response systems (IVRS), and screen-based systems. ePROM may be administered at a clinic or remotely in an unsupervised setting, such as the home or workplace. ...
AI Recruitment (AI-R) addresses clinical trial recruitment pain points for pharmaceutical companies and clinical research teams working to surface eligible patients for inflammatory bowel disease (IBD) clinical trials. Recruiting qualified patients is one of the most significant and expensive challenges of clinical trials, but AI-R helps determine if ...
In a debate format before hundreds of clinicians both on-line and in-person, the panel compared pressure-based vs volume-based measures to assess volume overload in advanced heart failure patients. The session was moderated by Dr. ...
Results from an analysis of prespecified patient subgroups were also presented, demonstrating generally consistent benefit across subgroups for the primary and secondary endpoints of 6-MWT and KCCQ-OS, respectively. As previously shared, patisiran also demonstrated an encouraging safety and tolerability profile in patients with ATTR amyloidosis with ...
In times of pandemic, cardiac rehabilitation centres search for solutions which allow them to continue remote rehabilitation, while making it possible to maintain constant contact with the patient. This solution must provide possibility to assess the patient's condition before training, set training parameters adjusted to individual needs and ...
The AeriSeal System is used to close collateral air channels in a target lung lobe of a patient with severe COPD/emphysema, making the patient eligible to then undergo Bronchoscopic Lung Volume Reduction (BLVR) with Zephyr Valves. ...